Biography 21: Mahlon Hoagland (1921- )

Mahlon Hoagland was born in Boston. His father was a research scientist with an interest in neurobiology. His dedication and passion for his work both drew and repelled the younger Hoagland, who learned first-hand what it was like to be a scientist. Hoagland knew fairly early on that he wanted a profession but wasn't sure that he wanted to be a scientist.

Hoagland decided he would be a medical doctor so as not to be in direct competition with his father. He went to college, first Williams College and then transferred to Harvard after a year. World War II had just started and with the need for medical doctors, Hoagland entered medical school even before graduating from college. He found he had the aptitude for being a surgeon ? he was manually adept and anatomy was one of his favorite classes. Unfortunately, three months before graduation, Hoagland was diagnosed with tuberculosis. He was sent to the Trudeau Sanatorium at Saranac Lake ? the same one where Phoebus Levene stayed ? for the classic bed rest cure. Treatment of tuberculosis with antibiotics wasn't available until near the end of his stay and by that time, Hoagland was deemed healthy enough.

In 1947, Hoagland returned to Harvard Medical School to finish his interrupted year. He still wanted to become a surgeon and applied to work as a surgical intern after graduation in 1948. It was soon obvious that he needed a less taxing career; after only weeks, Hoagland reactivated his tuberculosis. Disappointed, Hoagland applied for a postdoctoral position with Dr. Joseph Aub, the director of the Huntington Laboratories at Massachusetts General Hospital.

At Huntington, Hoagland learned to be a scientist. He worked on the effects of beryllium on enzymatic activity and in the process became more interested in biochemistry and the protein synthesis work going on in Paul Zamecnik's lab. Hoagland arranged sabbaticals to learn more about biochemistry with the goal of working in Zamecnik's lab on his return.

In 1953, Hoagland started work in Zamecnik's lab on the problem of amino acid activation. Using Zamecnik's cell-free system, Hoagland worked out the mechanics and published his results in 1955. He then began working on a project that Zamecnik had put on hold. This led to the discovery of tRNA, the adaptor (predicted by Francis Crick) that shuttles amino acids to messenger RNA. The results were published in 1957 and served to connect two fields of science research, biochemistry and molecular biology.

Hoagland spent 1958 at Cambridge University and worked with Francis Crick to try and use tRNA to solve the genetic code. He returned to the U.S. as associate professor of microbiology at Harvard Medical School. In his seven years at Harvard, Hoagland found great satisfaction in teaching and was distressed at the lack of "teachers" among the scientists who were only interested in research. He left Harvard to accept a position at Dartmouth Medical School where he improved the biochemistry curriculum.

In 1970, Hoagland accepted the directorship of the Worcester Foundation, the institute founded by his father. Hoagland was able to attract new researchers and established and strengthened research programs in cell biology, endocrinology, neurobiology, and reproductive biology at Worcester. In 1980, he was successful in recruiting Paul Zamecnik.

Although Hoagland is now retired, he still has a strong interest in education and teaching. Over the years, he has written a number of "non-scholarly" books on the subject of genes and molecular biology. The Way Life Works is being re-edited to be used as a textbook in high school biology classes. Hoagland lives in Vermont with his wife and as a hobby creates art by carving and sculpting wood.

Paul Zamecnik developed a cell-free extract that he and Mahlon Hoagland used to study protein synthesis. They identified tRNA as the adaptor predicted by Francis Crick in his Central Dogma

mahlon hoagland, francis crick, central dogma, saranac lake, treatment of tuberculosis, protein synthesis, enzymatic activity, sanatorium

  • ID: 16490
  • Source: DNALC.DNAFTB

Related Content

15001. Paul Zamecnik

Paul Zamecnik photo

  • ID: 15001
  • Source: DNAi

16489. Biography 21: Paul Charles Zamecnik (1913-2009)

Paul Zamecnik developed a cell-free extract that he and Mahlon Hoagland used to study protein synthesis. They identified tRNA as the adaptor predicted by Francis Crick in his Central Dogma

  • ID: 16489
  • Source: DNALC.DNAFTB

16471. Animation 21: RNA is an intermediary between DNA and protein.

Francis Crick describes RNA and its role and Paul Zamecnick explains protein synthesis.

  • ID: 16471
  • Source: DNALC.DNAFTB

15473. The Central Dogma: transcription and translation, James Watson

James Watson talks about the Central Dogma: transcription and translation.

  • ID: 15473
  • Source: DNAi

15876. The Central Dogma

James Watson and Francis Crick developed the idea to explain how DNA and RNA related in protein production.

  • ID: 15876
  • Source: DNAi

15015. Francis Crick and James Watson in Cambridge.

1953 picture of Francis Crick (L) and James Watson (R) walking along the backs of King's College in Cambridge.

  • ID: 15015
  • Source: DNAi

16475. Gallery 21: Mahlon Hoagland, 1999

Mahlon Hoagland at his home in Vermont, 1999.

  • ID: 16475
  • Source: DNAFTB

15474. RNA's role in the cell, James Watson

James Watson talks about RNA's role in the cell.

  • ID: 15474
  • Source: DNAi

15885. Cell-free extracts

Paul Zamecnik first developed the cell-free extract system, which Marshall Nirenberg adapted to decipher the genetic code. Paul Zamecnik and Mahlon Hoagland also isolated activated tRNA, the "adaptor" that shuttled amino acids to ribsomes for incorporati

  • ID: 15885
  • Source: DNAi